Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sweden
/
Hans Olof Glise
HO
Hans Olof Glise
Board of Directors, MCI, Medical consultant and Innovation Holding AB
Stockholm
SE
5 active roles
Watchlist
Share
Overview
Companies & roles
Network
Loading profile…
Companies & roles
Active roles
5 positions
Company
Role
Period
Ownership
Status
MCI, Medical consultant and Innovation Holding AB
CVR 5563578128
Board
Board of Directors
Since 2021
—
Active
Astra Hässle Aktiebolag
CVR 5564201225
Other
External Signatory
Since 2023
—
Dissolved
Nanofactory Instruments AB
CVR 5565670139
Board
Board of Directors
Since 2014
—
Dissolved
Accelerated Innovation mobile health, Europe AB
CVR 5569858961
Board
Deputy Board Member
Since 2022
—
Active
AI Cognitive Health AB
CVR 5590215777
Board
Deputy Board Member
Since 2022
—
Active
Historical roles
8 positions
Company
Role
Period
Ownership
Status
ITH Immune Therapy Holdings AB
CVR 5566814371
Board
Board of Directors
2020 – 2022
—
Active
TLA Targeted Immunotherapies AB
CVR 5567040042
Board
Board of Directors
2020 – 2022
—
Active
Accelerated Innovation, Europe AB
CVR 5569312175
Board
Board of Directors
2020 – 2022
—
Active
ISR Immune System Regulation Holding AB (publ)
CVR 5590267828
Board
Board of Directors
2022 – 2022
—
Active
CarryGenes Therapeutics AB
CVR 5591464689
Board
Board of Directors
2023 – 2023
—
Active
ISR Oncology AB
CVR 5591573760
Board
Board of Directors
2020 – 2023
—
Active
CarryGenes Oncology AB
CVR 5591961890
Board
Board of Directors
2020 – 2020
—
Active
ISR Vaccine AB
CVR 5593296147
Board
Board of Directors
2022 – 2022
—
Active
More on Hans Olof Glise
Overview →
Headline figures, risk signals and profile summary
Network →
Connections across other directors and entities